Atmo Biosciences: Chris Roberts

Chris Roberts has joined the board of Atmo Biosciences as a non-executive director. The Melbourne, Australia-based company is developing an ingestible gas-sensing capsule that can profile gases with the gut for better diagnosis and treatment of gastrointestinal disorders. Robers has more than 40 years of experience in the international medical device business, including as CEO of Cochlear and founding director and executive vice president of ResMed. Since retiring from Cochlear, he has been chairman of OncoSil Medical, as well as non-executive director of Clarity Pharmaceuticals and o'connell Street Associates.